See more : Aquafil S.p.A. (ECNL.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Acumen Pharmaceuticals, Inc. (ABOS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acumen Pharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Komatsu Ltd. (KMTUF) Income Statement Analysis – Financial Results
- TCC CONCEPT LIMITED (TCC.BO) Income Statement Analysis – Financial Results
- Rio Tinto Group (RIO) Income Statement Analysis – Financial Results
- PwrCor, Inc. (PWCO) Income Statement Analysis – Financial Results
- VEON Ltd. (VEON) Income Statement Analysis – Financial Results
Acumen Pharmaceuticals, Inc. (ABOS)
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.44M | 1.70M |
| Cost of Revenue | 42.32M | 169.00K | 4.00K | 8.00K | 8.58K |
| Gross Profit | -42.32M | -169.00K | -4.00K | 1.43M | 1.69M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 99.44% | 99.49% |
| Research & Development | 42.32M | 32.36M | 12.31M | 8.00M | 8.58M |
| General & Administrative | 18.82M | 12.88M | 7.28M | 1.35M | 926.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.82M | 12.88M | 7.28M | 1.35M | 926.00K |
| Other Expenses | 0.00 | -11.00K | 51.00K | 0.00 | 0.00 |
| Operating Expenses | 61.14M | 45.24M | 19.58M | 9.35M | 9.50M |
| Cost & Expenses | 61.14M | 45.24M | 19.58M | 9.35M | 9.50M |
| Interest Income | 10.21M | 2.39M | 84.00K | 1.00K | 45.00K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation & Amortization | 184.00K | 169.00K | 4.00K | 7.91M | 7.81M |
| EBITDA | -51.61M | -42.69M | 61.58M | 587.00K | 119.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -591.78% | -451.27% |
| Operating Income | -61.14M | -45.24M | 61.57M | -7.91M | -7.81M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -550.97% | -459.93% |
| Total Other Income/Expenses | 8.77M | 2.38M | -81.02M | 587.00K | -102.00K |
| Income Before Tax | -52.37M | -42.86M | -100.61M | -7.33M | -7.91M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -510.10% | -465.94% |
| Income Tax Expense | 0.00 | -2.38M | 81.07M | -1.00K | -45.00K |
| Net Income | -52.37M | -40.48M | -181.68M | -7.32M | -7.86M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -510.03% | -463.29% |
| EPS | -1.08 | -1.00 | -4.49 | -0.18 | -0.20 |
| EPS Diluted | -1.08 | -1.00 | -4.49 | -0.18 | -0.20 |
| Weighted Avg Shares Out | 48.49M | 40.60M | 40.47M | 40.15M | 40.15M |
| Weighted Avg Shares Out (Dil) | 48.61M | 40.60M | 40.47M | 40.15M | 40.15M |
Calldorado übernimmt das auf Nutzerakquise spezialisierte Unternehmen Appvestor
SØBORG, Kopenhagen (Dänemark)--(BUSINESS WIRE)--Calldorado hat den langjährigen Partner Appvestor übernommen, um seiner App-Entwickler-Community direkten Zugang zu fortschrittlichen Tools für die Nutzerakquise zu ermöglichen. Die beiden Unternehmen passen sehr gut zusammen. Beide haben es sich zum Ziel gesetzt, App-Entwickler bei ihrem...
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2021 and Business Highlights
CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimer's disease (AD), today reported financial results for the...
Comcast gibt die Aufnahme von Peacock in Sky bekannt
PHILADELPHIA & NEW YORK & LONDON--(BUSINESS WIRE)--Comcast gab heute bekannt, dass NBCUniversal und Sky Peacock ohne zusätzliche Kosten für nahezu 20 Millionen Sky-Kunden in Europa zur Verfügung stellen werden. Noch dieses Jahr wird Peacock sein internationales Debüt auf Sky-Plattformen feiern,...
5 Stocks With High Insider Cluster Buys During July
According to the Insider Cluster Buys Screen, a Premium feature of Gurus, five stocks with high number of unique insider buys during the past month include German American Bancorp Inc. ( GABC , Financial), Simon Property Group Inc. ( SPG...
The 5 biggest insider stock buys of last week
Here are the five companies that saw the biggest combined stock purchases from insiders during the week ended July 9.
AANA-VirtaMed Collaboration Results in Better Surgical Training
NASHVILLE, Tenn.--(BUSINESS WIRE)--The Arthroscopy Association of North America (AANA) and VirtaMed, the world leader in medical simulation training, will announce updated and enhanced training modules for hip joint surgeries. The announcement is the latest result of a collaboration agreement between...
Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering
CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (“Acumen” or “Acumen Pharmaceuticals”) (Nasdaq: ABOS), a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what Acumen believes to be a key underlying cause of Alzheimer's disease,...
Acumen Pharmaceuticals Pursues $125 Million IPO
Acumen Pharmaceuticals has filed proposed terms for a $125 million IPO. The firm is developing a treatment for Alzheimer's Disease.
Druva startet das branchenweit erste MSP-Programm mit der Einfachheit, Sicherheit und Skalierbarkeit einer SaaS-Plattform
SUNNYVALE, Kalifornien--(BUSINESS WIRE)--Druva Inc., der Marktführer im Bereich Cloud-Datensicherheit und -management, gab heute den Start seines neuen Programms für Managed Service Provider (MSP) bekannt. Das neue Programm und ist Teil des Druva Compass Partnerprogramms und soll MSPs dabei unterstützen, die...
Airship erweitert seine Plattform, um Live-Chat Funktion
MÜNCHEN--(BUSINESS WIRE)--Kunden erwarten heute, mit Unternehmen in Echtzeit kommunizieren und interagieren zu können. Gleichzeitig erleben viele Marketer, dass es immer schwieriger wird, neue Kunden zu halten. Die Customer-Engagement-Plattform Airship trägt dieser Entwicklung Rechnung und stellt mit Airship Live Chat die...
Source: https://incomestatements.info
Category: Stock Reports